Our data shows that in AML the cDC1 and cDC2 subsets are disrupted and the frequency of XCR1/cDC1 double-negative cDCs was significantly higher in FLT3-ITD+ samples. This evidence concerns the gene XCR1 and acute myeloid leukemia.